1. Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study
- Author
-
Soumita Mukherjee, Utpal Adhikari, Sujit S. Panja, Tapasendra Adhikary, and Subrata Dasgupta
- Subjects
Express Communication ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,viruses ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,030303 biophysics ,medicine.disease_cause ,03 medical and health sciences ,Structural Biology ,medicine ,Humans ,Protease Inhibitors ,Molecular Biology ,Coronavirus ,0303 health sciences ,SARS-CoV-2 ,Chemistry ,conserved water molecule ,COVID-19 ,virus diseases ,Hydroxychloroquine ,General Medicine ,Virology ,COVID-19 Drug Treatment ,Molecular Docking Simulation ,catalytic triad ,Research Article ,Peptide Hydrolases ,medicine.drug - Abstract
The spread of novel coronavirus strain, Severe Acute Respiratory Syndrome 2 (SARS-CoV-2) causes Coronavirus disease (COVID-19) has now spread worldwide and effecting the entire human race. The viral genetic material is transcripted and replicated by 3 C-like protease, as a result, it is an important drug target for COVID-19. Hydroxychloroquine (HCQ) report promising results against this drug target so, we perform molecular docking followed by MD-simulation studies of HCQ and modelled some ligand (Mod-I and Mod-II) molecules with SARS-CoV-2-main protease which reveals the structural organization of the active site residues and presence of a conserve water-mediated catalytic triad that helps in the recognition of Mod-I/II ligand molecules. The study may be helpful to gain a detailed structural insight on the presence of water-mediated catalytic triad which could be useful for inhibitor modelling. Communicated by Ramaswamy H. Sarma
- Published
- 2020
- Full Text
- View/download PDF